CSPI's complaint against EpicGenetics for false and misleading marketing of laboratory-developed tests

According to the complaint, EpicGenetics falsely claims its FM/a Test for fibromyalgia is “99 percent accurate” when the company’s own study indicates it generates false negative test results 7 percent of the time, and false positives nearly one-third of the time for individuals with rheumatoid arthritis or lupus.